Delivery Order SPE2DB22D1106-SPE2DB24FDJE9
- Not listed
- The federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $81,069.66, is a delivery order with a firm fixed price under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This single-award IDC, valued at...
- This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA). The $19,881.67 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,779.46 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA). The $22,524.94 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC,...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $77,919.37, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA). The $9,340.32 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This single-award IDC serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,721.08 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes, with a completion date of July 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGE medical products to the Defense Logistics Agency (DLA), a defense agency. The $19,800.39 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on July 14, 2022, with a completion date of July 15, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $14,751.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to federal agencies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award is for the procurement of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order valued at $51,231.48 with a firm fixed price pricing type. It has an ultimate completion date of January 12, 2024. This award is part of a larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDJE9Delivery Order
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA). The $14,511.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, enables the efficient procurement of essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical supplies across multiple therapeutic areas. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 10/23/23 |